FDA Warning Letter — American Specialty Pharmacy
The FDA took a Warning Letter action against American Specialty Pharmacy on April 4, 2017 (Dallas, TX). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.
Action Details
- Facility
- American Specialty Pharmacy
- Date
- April 4, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Center
- CDER
- Location
- Dallas, TX (United States)